Cargando…

A Class I Histone Deacetylase Inhibitor Attenuates Insulin Resistance and Inflammation in Palmitate-Treated C2C12 Myotubes and Muscle of HF/HFr Diet Mice

Histone deacetylase (HDAC) inhibitors, which regulate gene expression by inhibiting the deacetylation of histones and nonhistone proteins, have been shown to exert a wide array of biological effects; these include anti-cancer, anti-obesity, and anti-diabetes effects, as well as cardiovascular-protec...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Soo Jin, Choi, Sung-E, Lee, Han Byeol, Song, Min-Woo, Kim, Young Ha, Jeong, Jae Yeop, Kang, Yup, Kim, Hae Jin, Kim, Tae Ho, Jeon, Ja Young, Lee, Kwan Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758468/
https://www.ncbi.nlm.nih.gov/pubmed/33362555
http://dx.doi.org/10.3389/fphar.2020.601448
_version_ 1783626946770370560
author Lee, Soo Jin
Choi, Sung-E
Lee, Han Byeol
Song, Min-Woo
Kim, Young Ha
Jeong, Jae Yeop
Kang, Yup
Kim, Hae Jin
Kim, Tae Ho
Jeon, Ja Young
Lee, Kwan Woo
author_facet Lee, Soo Jin
Choi, Sung-E
Lee, Han Byeol
Song, Min-Woo
Kim, Young Ha
Jeong, Jae Yeop
Kang, Yup
Kim, Hae Jin
Kim, Tae Ho
Jeon, Ja Young
Lee, Kwan Woo
author_sort Lee, Soo Jin
collection PubMed
description Histone deacetylase (HDAC) inhibitors, which regulate gene expression by inhibiting the deacetylation of histones and nonhistone proteins, have been shown to exert a wide array of biological effects; these include anti-cancer, anti-obesity, and anti-diabetes effects, as well as cardiovascular-protective activity. However, the effects of class I HDAC inhibition on lipotoxicity in C2C12 myotubes and skeletal muscle tissue remain poorly understood. In this study, we investigated the molecular mechanism underlying the protective effect of class I HDAC inhibition under lipotoxic conditions, i.e., in palmitate (PA)-treated C2C12 myotubes and skeletal muscle tissue in high fat (HF)/high fructose (HFr) diet mice. PA treatment of C2C12 myotubes increased HDAC3 protein expression and impaired mitochondrial oxidation, resulting in increased mitochondrial ROS generation and an accumulation of intracellular triglycerides (TG). Prolonged exposure led to increased inflammatory cytokine expression and insulin resistance. In contrast, MS-275, a class I HDAC inhibitor, dramatically attenuated lipotoxicity, preventing PA-induced insulin resistance and inflammatory cytokine expression. Similar beneficial effects were also seen following HDAC3 knockdown. In addition, MS-275 increased the mRNA expression of peroxisome proliferator activator receptor γ-coactivator 1α (PGC1α) and mitochondrial transcription factor A (TFAM), which serve as transcriptional coactivators in the context of mitochondrial metabolism and biogenesis, and restored expression of peroxisome proliferator-activated receptor alpha (PPARα), medium-chain acyl-coenzyme A dehydrogenase (MCAD), enoyl-CoA hydratase, and 3-hydroxyacyl CoA dehydrogenase (EHHADH). In vivo, treatment of HF/HFr-fed mice with MS-275 ameliorated hyperglycemia, insulin resistance, stress signals, and TNF-α expression in skeletal muscle. Taken together, these results suggest that HDAC3 inhibition rather than HDAC1/2 inhibition by MS-275 protects against lipotoxicity in C2C12 myotubes and skeletal muscle, and may be effective for the treatment of obesity and insulin resistance.
format Online
Article
Text
id pubmed-7758468
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77584682020-12-25 A Class I Histone Deacetylase Inhibitor Attenuates Insulin Resistance and Inflammation in Palmitate-Treated C2C12 Myotubes and Muscle of HF/HFr Diet Mice Lee, Soo Jin Choi, Sung-E Lee, Han Byeol Song, Min-Woo Kim, Young Ha Jeong, Jae Yeop Kang, Yup Kim, Hae Jin Kim, Tae Ho Jeon, Ja Young Lee, Kwan Woo Front Pharmacol Pharmacology Histone deacetylase (HDAC) inhibitors, which regulate gene expression by inhibiting the deacetylation of histones and nonhistone proteins, have been shown to exert a wide array of biological effects; these include anti-cancer, anti-obesity, and anti-diabetes effects, as well as cardiovascular-protective activity. However, the effects of class I HDAC inhibition on lipotoxicity in C2C12 myotubes and skeletal muscle tissue remain poorly understood. In this study, we investigated the molecular mechanism underlying the protective effect of class I HDAC inhibition under lipotoxic conditions, i.e., in palmitate (PA)-treated C2C12 myotubes and skeletal muscle tissue in high fat (HF)/high fructose (HFr) diet mice. PA treatment of C2C12 myotubes increased HDAC3 protein expression and impaired mitochondrial oxidation, resulting in increased mitochondrial ROS generation and an accumulation of intracellular triglycerides (TG). Prolonged exposure led to increased inflammatory cytokine expression and insulin resistance. In contrast, MS-275, a class I HDAC inhibitor, dramatically attenuated lipotoxicity, preventing PA-induced insulin resistance and inflammatory cytokine expression. Similar beneficial effects were also seen following HDAC3 knockdown. In addition, MS-275 increased the mRNA expression of peroxisome proliferator activator receptor γ-coactivator 1α (PGC1α) and mitochondrial transcription factor A (TFAM), which serve as transcriptional coactivators in the context of mitochondrial metabolism and biogenesis, and restored expression of peroxisome proliferator-activated receptor alpha (PPARα), medium-chain acyl-coenzyme A dehydrogenase (MCAD), enoyl-CoA hydratase, and 3-hydroxyacyl CoA dehydrogenase (EHHADH). In vivo, treatment of HF/HFr-fed mice with MS-275 ameliorated hyperglycemia, insulin resistance, stress signals, and TNF-α expression in skeletal muscle. Taken together, these results suggest that HDAC3 inhibition rather than HDAC1/2 inhibition by MS-275 protects against lipotoxicity in C2C12 myotubes and skeletal muscle, and may be effective for the treatment of obesity and insulin resistance. Frontiers Media S.A. 2020-12-10 /pmc/articles/PMC7758468/ /pubmed/33362555 http://dx.doi.org/10.3389/fphar.2020.601448 Text en Copyright © 2020 Lee, Choi, Lee, Song, Kim, Jeong, Kang, Kim, Kim, Jeon and Lee http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Lee, Soo Jin
Choi, Sung-E
Lee, Han Byeol
Song, Min-Woo
Kim, Young Ha
Jeong, Jae Yeop
Kang, Yup
Kim, Hae Jin
Kim, Tae Ho
Jeon, Ja Young
Lee, Kwan Woo
A Class I Histone Deacetylase Inhibitor Attenuates Insulin Resistance and Inflammation in Palmitate-Treated C2C12 Myotubes and Muscle of HF/HFr Diet Mice
title A Class I Histone Deacetylase Inhibitor Attenuates Insulin Resistance and Inflammation in Palmitate-Treated C2C12 Myotubes and Muscle of HF/HFr Diet Mice
title_full A Class I Histone Deacetylase Inhibitor Attenuates Insulin Resistance and Inflammation in Palmitate-Treated C2C12 Myotubes and Muscle of HF/HFr Diet Mice
title_fullStr A Class I Histone Deacetylase Inhibitor Attenuates Insulin Resistance and Inflammation in Palmitate-Treated C2C12 Myotubes and Muscle of HF/HFr Diet Mice
title_full_unstemmed A Class I Histone Deacetylase Inhibitor Attenuates Insulin Resistance and Inflammation in Palmitate-Treated C2C12 Myotubes and Muscle of HF/HFr Diet Mice
title_short A Class I Histone Deacetylase Inhibitor Attenuates Insulin Resistance and Inflammation in Palmitate-Treated C2C12 Myotubes and Muscle of HF/HFr Diet Mice
title_sort class i histone deacetylase inhibitor attenuates insulin resistance and inflammation in palmitate-treated c2c12 myotubes and muscle of hf/hfr diet mice
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758468/
https://www.ncbi.nlm.nih.gov/pubmed/33362555
http://dx.doi.org/10.3389/fphar.2020.601448
work_keys_str_mv AT leesoojin aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT choisunge aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT leehanbyeol aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT songminwoo aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT kimyoungha aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT jeongjaeyeop aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT kangyup aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT kimhaejin aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT kimtaeho aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT jeonjayoung aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT leekwanwoo aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT leesoojin classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT choisunge classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT leehanbyeol classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT songminwoo classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT kimyoungha classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT jeongjaeyeop classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT kangyup classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT kimhaejin classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT kimtaeho classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT jeonjayoung classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice
AT leekwanwoo classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice